Discover the link between systemic inflammation and chiropractic rehabilitation for a healthier, pain-free lifestyle.

Abstract

In this comprehensive educational post, I present an evidence-based, first-person narrative on systemic inflammation and its far-reaching impact on human health. Drawing on modern immunology, cutting-edge clinical research, and multidisciplinary care strategies at our clinic in El Paso, Texas, I explain how persistent immune activation—characterized by macrophage polarization, cytokine dysregulation, and impaired immune regulation—drives chronic disease across systems. I detail how integrative chiropractic care fits into an upstream approach to regulation, alongside functional medicine, internal medicine oversight, and personal injury rehabilitation. I also highlight the collaborative role of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), who serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), partnering with me (Dr. Alex Jimenez, DC) in a multidisciplinary model. We explore physiological mechanisms—including microglial activation, BDNF suppression, immunosenescence, thymic regulation, Treg circuitry, and metabolic-inflammation links—and why this integrated approach aligns with the latest findings (e.g., associations of IL-6 and TNF-alpha with all-cause mortality; inflammaging’s contribution to cardiometabolic and neurodegenerative disease). Finally, I share clinical observations from my practice and outline step-by-step protocols for assessment, treatment, and long-term recovery.

Keywords summary: systemic inflammation, macrophage polarization, M1/M2, IL-6, TNF-alpha, microglia, BDNF, thymic regulation, Treg function, inflammaging, functional medicine, integrative chiropractic, rehabilitation, personal injury care, multidisciplinary collaboration.

Systemic Inflammation: How a Dysregulated Immune Loop Drives Chronic Disease

I want to guide you through a clear understanding of systemic inflammation from my clinical perspective and the latest evidence. Systemic inflammation is what happens when the immune system doesn’t appropriately turn off or complete the healing cycle. The innate immune system—especially macrophages—plays a central role. When these cells become stuck in a persistent pro-inflammatory mode, they continuously release cytokines such as TNF-alpha and IL-6 into the bloodstream. This sustained activation creates a high-alert physiological state that gradually damages tissues, disrupts cellular communication, and impairs organ systems.

• The core concept: an incomplete inflammatory cycle generates persistent signaling that drives multi-organ dysfunction.
• My clinical observation: patients rarely present with one isolated problem. Instead, I see clusters of symptoms—metabolic, neurological, musculoskeletal, gastrointestinal, and cardiovascular—often traceable to the same upstream inflammatory biology.

From a population health standpoint, elevated inflammatory markers correlate strongly with poor outcomes. Landmark analyses have shown that high levels of IL-6 and TNF-alpha are independent predictors of all-cause mortality, with hazard ratios comparable to known risks like smoking (Balachandran et al., 2022; see linked references below). These data underscore why addressing systemic inflammation is not merely symptom management—it is foundational risk modification.

What makes this phenomenon so consequential is its pervasiveness: in systemic inflammation, the same destructive immune phenotype operates across tissues simultaneously. Adipose tissue, liver, kidneys, vascular endothelium, and the brain are particularly vulnerable. As a clinician trained in chiropractic, functional medicine, and advanced rehabilitation, I see how musculoskeletal complaints, brain fog, mood changes, glucose dysregulation, hypertension, and pain syndromes often converge within this same inflammatory matrix. When we stabilize the inflammatory loop, the downstream improvements can be surprisingly broad.

Macrophage Polarization: Understanding M1 and M2 States

To appreciate how systemic inflammation works, we need to understand macrophage polarization and its functional spectrum:

• M1 macrophages (pro-inflammatory):

• • Produce cytokines like TNF-alpha, IL-6, IL-1.
  • Generate reactive oxygen species (ROS).
  • Focus on pathogen clearance and damage containment.
  • In shorthand: “burn it down” mode—clearing threats aggressively but risking collateral damage when unregulated.

• M2 macrophages (anti-inflammatory and reparative):

• • Produce IL-10, TGF-A, and enzymes like arginase-1.
  • Clear cellular debris, support angiogenesis, and coordinate tissue repair.
  • Complete the inflammatory cycle by promoting resolution and regeneration.
  • In shorthand: “clean it up” mode—moving biology back to homeostasis.

Clinical relevance:

• Chronic disease often reflects biology stuck on the M1 pole, without adequate transition to M2-mediated resolution.
• We assess inflammatory load using symptom clusters, physical exam findings (tender points, edema, temperature asymmetry), functional testing (CRP, ESR, IL-6 where feasible), and adjacent markers (fasting insulin, HOMA-IR, ferritin as an acute-phase reactant).
• Treatment must encourage a transition from M1 dominance to balanced M2 activity by regulating upstream signals, supporting mitochondrial function, maintaining redox balance, and integrating neuroimmune pathways.

Physiological underpinnings:

• Microenvironmental signals shape macrophage phenotype: pathogen-associated molecular patterns (PAMPs), damage-associated molecular patterns (DAMPs), cytokine milieu (IFN-? drives M1; IL-4/IL-13 bias toward M2), metabolic substrate availability (glucose vs. fatty acid oxidation), and mitochondrial function.
• M1 macrophages preferentially rely on glycolysis, generating rapid energy and ROS, while M2 macrophages favor oxidative phosphorylation, aligning with repair processes.
• Restoring metabolic flexibility at the cellular level—supporting mitochondrial efficiency and reducing excessive glycolytic drive in immune cells—helps normalize phenotype.

Why this matters:

• You cannot “out-supplement” or “out-adjust” a persistently M1-skewed system without addressing the upstream drivers: nutrient signaling, sleep architecture, stress axis regulation, toxin load, microbiome balance, and physical load on tissues. Our integrative model is designed to do exactly that.

Inflammaging: Chronic Low-Grade Inflammation as a Unifying Mechanism

A growing body of research shows that chronic low-grade inflammation—often called inflammaging—serves as a unifying pathophysiology across cardiometabolic and neurodegenerative conditions. Large translational and clinical cohorts have demonstrated links between persistent inflammatory signaling and conditions such as type 2 diabetes, insulin resistance, atherosclerosis, heart failure, dementia, and certain cancers (Franceschi et al., 2018; Furman et al., 2019; Nature Medicine perspectives and cross-disease analyses).

• The central message: if we fix systemic inflammation, we address overlapping roots of multiple chronic diseases simultaneously.
• Clinical pattern recognition: in our practice, the same patient presenting with back pain post-injury often also shows evidence of metabolic stress (elevated fasting insulin), sleep fragmentation, mood changes, and cognitive fatigue—all compatible with a low-grade inflammatory state.

Mechanisms:

• Adipose tissue inflammation drives hepatic insulin resistance via cytokines and free fatty acids.
• Vascular endothelium responds to inflammatory cytokines with reduced nitric oxide bioavailability, increased adhesion molecules, and accelerated plaque formation.
• Neurons and glia lose trophic support as inflammatory mediators inhibit BDNF (brain-derived neurotrophic factor), compromising neuroplasticity.
• The immune system’s regulatory arms (Tregs) weaken under persistent stress, allowing autoreactivity and chronic damage.

Clinical insight:

• In our multidisciplinary approach, we codify inflammation patterns across systems and address them at multiple levels—mechanical, nutritional, neuroendocrine, and psychosocial—in one cohesive plan.

Neuroinflammation and Microglia: When the Brain’s Macrophages Become Dysregulated

Your brain has its own resident macrophages called microglia. When microglia shift into chronic M1 activation, they produce pro-inflammatory cytokines and ROS that damage synapses, degrade white matter integrity, and suppress trophic signals like BDNF.

• Functional impact: impaired neuroplasticity, memory consolidation issues, slowed processing speed, mood dysregulation, and sleep fragmentation.
• Clinical presentation: brain fog, emotional lability, fatigue, and heightened sensory sensitivity—symptoms I track carefully in personal injury and post-concussive patients.

Neurodegenerative connections:

• Alzheimer’s disease, Parkinson’s disease, vascular dementia, and depression share neuroinflammatory threads in their pathophysiology (Heneka et al., 2015; Holmes et al., 2009).
• The same core principle applies: resolving inflammation restores neural function by permitting synaptic repair, supporting remyelination, and improving network connectivity.

Why chiropractic integration helps:

• Mechanical input from the cervical spine influences autonomic tone and brainstem nuclei. Proper segmental motion, soft-tissue normalization, and postural correction can improve vagal tone, reduce sympathetic overdrive, and modulate central pain processing.
• Our integrative chiropractic interventions are paired with functional medicine strategies—sleep optimization, micronutrient repletion, glymphatic support through positional therapy and adequate slow-wave sleep—to create a synergistic effect on neuroimmune regulation.

Thymic Regulation and T-Cell Quality Control: The Role of Tregs

The thymus is a crucial organ for immune education. Through positive and negative selection, it trains T cells to recognize pathogens while avoiding attacks on the body’s own tissues. When thymic signaling falters or when peripheral tolerance is impaired, autoreactive T cells can escape regulation and contribute to systemic inflammatory loops.

• Regulatory T cells (Tregs) are central to maintaining immune balance. They help resolve inflammation and prevent inappropriate immune activation.
• Persistent systemic inflammation reduces Treg functionality, impairs tolerance, and propagates chronic disease.

Clinical takeaway:

• In practice, I don’t frame these conditions as “mysterious autoimmune disorders detached from physiology.” Rather, I evaluate them as manifestations of a misdirected immune system within an inflammatory context. When we restore regulation—through sleep, nutrition, stress modulation, chiropractic neuro-musculoskeletal normalization, and immunomodulatory therapies—the immune system often stabilizes.

Potential modulators:

• Peptide therapies such as Thymosin alpha-1 (Ta1) have been studied for their ability to modulate immune responses, support Treg function, and rebalance immune phenotypes (Gao et al., 2010; Palmieri et al., 2013). In selected cases and under medical oversight, such approaches may help shift macrophages from M1 to M2 tendencies and reduce chronic inflammatory signaling.
• All pharmacologic or peptide interventions are considered within a medically directed framework in our clinic, ensuring safety, appropriateness, and monitoring.

Integrative Chiropractic Care Within a Medically Directed Multidisciplinary Clinic

I direct chiropractic care that is fully integrated with internal medicine oversight, functional medicine protocols, rehabilitation, and personal injury services. This model allows us to implement sophisticated upstream regulation while maintaining rigorous medical safety and monitoring.

• Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933) serves as Medical Director and Collaborative Physician at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas.
• With more than 40 years of experience as an internist, Dr. Cardenas collaborates with me (Dr. Alex Jimenez, DC) to unify chiropractic interventions with medical diagnostics, medication management when appropriate, and functional medicine plans tailored to the patient’s inflammatory profile.

How our collaboration works:

• We conduct joint case reviews, especially for complex systemic inflammation, cardiometabolic risk, neurological symptoms, and personal injury cases.
• Cardenas provides medical direction for diagnostics (e.g., labs, imaging, cardiovascular and endocrine assessments), medication considerations, and peptide therapy oversight.
• I lead chiropractic neuro-musculoskeletal evaluation, functional movement analysis, soft-tissue and joint regulation, and integrative rehabilitation.
• Our functional medicine team addresses nutrition, microbiome balance, sleep architecture, stress physiology, and lifestyle prescriptions.

Why this integration matters:

• A single care pathway lets us coordinate upstream regulation—mechanical alignment, autonomic balance, immune modulation, metabolic recalibration—so patients can improve across multiple symptom domains.

Clinical Observations From My Practice in El Paso, Texas

Across personal injury, chronic pain, and functional medicine care, I consistently observe the following patterns (see clinical insights shared on my platforms: Personal Injury Doctor Group and LinkedIn):

• Pain and stiffness correlate with systemic inflammatory markers, not just local structural issues.
• Patients with persistent neck or back pain often exhibit sleep fragmentation, increased resting heart rate, and elevated perceived stress—consistent with heightened sympathetic tone and inflammatory priming.
• Nutritional insufficiencies (e.g., magnesium, omega-3s, vitamin D) amplify inflammatory responses and slow tissue healing.
• Microbiome disruption (post-antibiotic or from dietary imbalance) increases gut permeability, fueling systemic inflammation via LPS (lipopolysaccharide) translocation.
• When mechanical faults are corrected—improved cervical alignment, thoracic mobility, hip and pelvic stabilization—patients report better cognitive clarity and emotional resilience, suggesting a neuroimmune connection.

These observations drive our protocols:

• We blend chiropractic adjustments with soft-tissue techniques, corrective exercise, breathwork, and vagal tone training.
• Functional medicine plans include elimination of inflammatory dietary triggers, mitochondrial support, glycemic control, and sleep optimization.
• Medical oversight ensures appropriate testing, medication taper or initiation when necessary, and advanced therapies (e.g., supervised peptide use or cardiometabolic risk management).

References to my professional activities and case narratives can be found via:

• Personal Injury Doctor Group: https://personalinjurydoctorgroup.com/
• LinkedIn profile: https://www.linkedin.com/in/dralexjimenez/

The Physiology of Chronic Inflammation: From Cell Danger Response to Tissue Dysfunction

To treat effectively, I help patients grasp why chronic inflammation unfolds the way it does:

• Cell danger response (CDR): When cells perceive threats—infectious agents, toxins, mechanical overload—they initiate defense behaviors that include cytokine release, metabolic shift to glycolysis, and reduced repair activities. When the threat is ongoing, or resolution fails, CDR persists, promoting systemic inflammation.
• Oxidative stress and redox imbalance: Excess ROS damage lipids, proteins, and DNA, inhibit repair enzymes, and promote further immune activation. We measure or infer this state via clinical signs and support with antioxidants and mitochondrial cofactors under medical guidance.
• Mitochondrial dysfunction: Inflammation impairs mitochondrial efficiency, reducing ATP and increasing ROS. This creates fatigue, muscle weakness, poor recovery from exercise or injury, and cognitive downshifts.
• Autonomic imbalance: Sympathetic overdrive reduces perfusion to digestive tissues, impairs sleep, and elevates blood pressure—feeding back into inflammatory loops.

Why we target regulation:

• Normal physiology cycles from threat response to resolution and repair. Our interventions push biology toward completion of that cycle—lowering inflammatory signals, restoring mitochondrial function, and enhancing parasympathetic tone.

How Integrative Chiropractic Care Modulates Inflammation

Chiropractic care is often perceived as purely structural, but its effects extend into neuroimmune regulation:

• Segmental motion and mechanoreception: Spinal adjustments increase proprioceptive input, which can dampen nociception and modulate central processing in the dorsal horn and supraspinal centers.
• Autonomic modulation: Cervical and thoracic adjustments, along with soft-tissue normalization, influence sympathetic-parasympathetic balance. Improved vagal tone can reduce systemic inflammatory signaling.
• Muscle and fascia: Releasing myofascial adhesions reduces nociceptive input and local inflammatory mediator production. Fascia is bioactive; tension patterns can sustain cytokine release and hypoperfusion.

Why this is evidence-based:

• Clinical outcomes show reductions in pain severity, improved range of motion, and better functional capacity. While not a panacea, chiropractic interventions are a key piece of an anti-inflammatory strategy when integrated with medical and functional medicine care.

Functional Medicine Pillars: Nutrition, Sleep, Stress, and Microbiome

To shift biology from chronic M1 activation toward balanced M2 repair, we address core lifestyle domains:

Nutrition:

• Anti-inflammatory dietary patterns: Emphasize omega-3 fatty acids, polyphenols, fiber, and nutrient-dense whole foods. Reduce refined sugars, trans fats, and ultra-processed foods.
• Glycemic control: Stabilize insulin dynamics via low-glycemic meals, adequate protein, and timed carbohydrate intake.
• Micronutrient repletion: Magnesium, vitamin D, zinc, selenium, and B vitamins support immune regulation and mitochondrial function.

Sleep:

• Prioritize slow-wave and REM sleep to enhance glymphatic clearance and BDNF expression.
• Implement circadian entrainment: maintain a consistent wake time, get morning light exposure, and minimize late-night stimulants.

Stress physiology:

• Breathwork, mindfulness, and graded exercise recalibrate autonomic tone.
• Cognitive-behavioral strategies address catastrophizing and fear-avoidance patterns in pain.

Microbiome:

• Increase dietary diversity to promote short-chain fatty acid production (e.g., butyrate).
• Consider probiotics or targeted antimicrobials under medical supervision when dysbiosis is identified.
• Restore gut barrier function with nutrients like glutamine and zinc carnosine where appropriate.

Personal Injury Care and Rehabilitation: Resolving the Inflammatory Cascade

In injury care, acute inflammation is necessary for healing. Problems arise when the inflammatory cycle remains incomplete:

• Phased approach:

• • Acute phase: control pain, protect tissues, and maintain gentle mobility to prevent stagnation.
  • Subacute phase: restore joint play and soft tissue elasticity; introduce neuromuscular retraining.
  • Remodeling phase: strengthen kinetic chains, correct posture, and enhance endurance to resist reinjury.

• Clinical reasoning:

• • Early motion stimulates lymphatic clearance and reduces localized cytokine accumulation.
  • Neuromuscular retraining improves motor unit recruitment and reduces compensatory strain patterns that perpetuate microinflammation.
  • Graded loading increases mitochondrial biogenesis and strengthens collagen alignment.

Team integration:

• Cardenas oversees medical aspects—imaging, analgesic strategies, monitoring for complications like complex regional pain syndrome (CRPS), and screening cardiometabolic risks revealed during recovery.
• I coordinate manual therapy, adjustments, and corrective exercise progressions tailored to the individual’s inflammatory recovery status.

Unlocking the Secrets of Inflammation: Integrative Medicine Approach- Video

Evidence-Based Immunomodulatory Options and Medical Oversight

In selected patients with persistent dysregulation, we explore immunomodulatory agents under medical supervision:

• Thymosin alpha-1 (Ta1): Studied for enhancing Treg function, modulating dendritic cell activity, and improving host defense (Gao et al., 2010; Palmieri et al., 2013).
• Metabolic modulators: In cases of insulin resistance, medications like metformin may be considered to target metabolic-inflammation links, with lifestyle intervention at the core.
• Lipid management: Statins can reduce vascular inflammation markers and may be used judiciously alongside diet and exercise plans.
• SSRIs and neuroinflammation: Where mood disorders co-exist, SSRIs may moderate inflammation indirectly through improved sleep and mood regulation; we prefer upstream lifestyle changes first, medications when indicated.

Safety:

• Cardenas ensures indications, contraindications, dosing, and monitoring are appropriate. We maintain transparent communication with patients about the goals: reducing upstream inflammatory drivers with minimal reliance on downstream symptom control.

Assessing Inflammation: Practical Tools and Clinical Markers

Our evaluation blends traditional medical testing with functional assessments:

• Laboratory markers:

• • CRP, ESR
  • IL-6 where feasible
  • Fasting insulin, HbA1c, lipid profile (TG/HDL ratio)
  • Ferritin, homocysteine
  • Vitamin D, omega-3 index

• Autonomic and functional tests:

• • Resting heart rate, heart rate variability (HRV)
  • Sleep tracking (validated wearables or polysomnography when needed)
  • Pain questionnaires (VAS, Oswestry, Neck Disability Index)

Interpretation strategy:

• We avoid over-reliance on any single marker. Patterns across systems guide the plan: metabolic stress plus elevated CRP plus poor sleep equals high probability of inflammaging. Clinical response to intervention is a crucial test of our hypothesis.

Protocol Blueprint: Step-by-Step Plan to Rebalance the Immune System

We apply a layered approach, tailored to each patient:

• Phase 1: Stabilize

• • Reduce acute pain and inflammatory triggers.
  • Normalize sleep-wake cycles.
  • Initiate gentle mobilization and breathwork.
  • Begin anti-inflammatory nutrition and hydration.

• Phase 2: Rebuild

• • Correct spinal and joint mechanics via chiropractic care.
  • Soft-tissue normalization and fascial release.
  • Strengthen key kinetic chains (gluteal complex, deep cervical flexors, scapular stabilizers).
  • Add micronutrient repletion and mitochondrial cofactors.

• Phase 3: Regulate

• • Intensify vagal tone training (HRV biofeedback, paced breathing).
  • Expand dietary diversity for microbiome resilience.
  • Consider medical immunomodulators if persistent dysregulation remains.
  • Reassess labs and functional markers; iterate.

• Phase 4: Resilience

• • Introduce higher-level conditioning and cognitive challenges.
  • Maintain stress management routines.
  • Periodic tune-ups: chiropractic maintenance, functional medicine check-ins, medical follow-up.

Rationale:

• Each phase targets specific physiology: pain and sleep first (reduce sympathetic drive), then mechanics (reduce nociception), then immune regulation (support Treg and M2 signaling), then resilience (train systems to prevent relapse).

Case Vignettes and Practice Patterns: What We See in El Paso

While individual details remain confidential, common patterns illustrate how systemic inflammation manifests and responds:

• Post-accident whiplash with brain fog:

• • Findings: cervical hypomobility, trapezius hypertonicity, poor sleep, elevated resting HR.
  • Plan: cervical adjustments, soft-tissue work, guided breathwork, anti-inflammatory nutrition, magnesium repletion, sleep timing.
  • Outcome: improved range of motion, reduced pain intensity, clearer cognition.

• Chronic low back pain with metabolic syndrome:

• • Findings: central adiposity, elevated fasting insulin, mildly elevated CRP, poor endurance.
  • Plan: lumbar-pelvic stabilization, gluteal strengthening, low-glycemic nutrition, omega-3s, sunlight exposure.
  • Outcome: pain reduction, improved lab markers, increased energy.

• Diffuse pain with mood symptoms:

• • Findings: hypersensitivity to pressure, sleep fragmentation, rumination, sedentary pattern.
  • Plan: gentle mobilization, graded activity, mindfulness training, nutrient repletion, HRV targets.
  • Outcome: improved tolerance to activity, mood stabilization, better sleep.

These reflect a broader truth: integrating chiropractic mechanics, functional medicine, and medical oversight produces multi-system benefits by addressing upstream physiology rather than isolated symptoms.

Why “Fixing Regulation” Fixes Many Symptoms at Once

I often tell patients: you don’t have ten separate diseases—you have one dysregulated biology producing ten different symptoms. When we restore the body’s regulatory systems, multiple issues improve simultaneously.

• Inflammation resolution restores endothelial function and reduces atherosclerotic progression.
• Metabolic recalibration improves insulin sensitivity and energy stability.
• Autonomic balance enhances sleep quality, digestion, and pain thresholds.
• Neuroimmune normalization allows synaptic repair and better cognition.

This is not oversimplification; it is systems biology applied to everyday clinical practice. Our integrated model ensures each lever—mechanical, metabolic, neuroendocrine, immune—is addressed coherently.

The Role of Evidence-Based Research in Our Protocols

We rely on rigorous research to guide our approach:

• Elevated IL-6 and TNF-alpha predict mortality: findings suggest cytokine burden is not a benign byproduct but a risk comparable to major lifestyle factors (Balachandran et al., 2022).
• Inflammaging links to cardiometabolic and neurodegenerative disease: multi-cohort analyses and mechanistic studies show unified pathways (Franceschi et al., 2018; Furman et al., 2019).
• Microglial activation and neurodegeneration: neuroinflammatory processes play key roles in Alzheimer’s and related disorders (Heneka et al., 2015; Holmes et al., 2009).
• Thymic regulation and Treg support: immunomodulation via peptides like Thymosin alpha-1 is an area of ongoing research with promising regulatory impacts (Gao et al., 2010; Palmieri et al., 2013).

We continuously adjust protocols based on emerging evidence, patient response, and safety oversight from our medical director.

Practical Action Plan for Patients

To start moving your physiology from chronic inflammation back to regulation:

• Prioritize sleep: set consistent bed and wake times; aim for 7–8 hours; dim lights at night; morning light exposure.
• Eat anti-inflammatory meals: emphasize omega-3s (fatty fish), colorful vegetables, olive oil, nuts, seeds; limit sugars and processed foods.
• Move daily: gentle mobility, walking, and progressive strength training.
• Practice breathwork: 5–10 minutes of paced breathing (e.g., 4-second inhale, 6-second exhale) to stimulate vagal tone.
• Reduce toxic load: avoid smoking; moderate alcohol; filter water when needed; focus on air quality and clean household products.
• Seek integrated care: chiropractic evaluation for mechanics; functional medicine for lifestyle and micronutrient guidance; medical oversight for diagnostics and medications when appropriate.

The Team at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic)

In El Paso, Texas, our multidisciplinary clinic is structured for integrative regulation:

• Medical direction: Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine (NPI #1164426749; Texas MD License #J2933), serves as Medical Director and Collaborative Physician.
• Chiropractic and functional care: I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, lead chiropractic services and integrative rehabilitation, focusing on upstream inflammation control.
• Coordinated services: personal injury care, physical rehabilitation, nutrition counseling, stress physiology coaching, and when indicated, medically supervised peptides and pharmacologic therapies.

This multidisciplinary model mirrors best practices in integrative and injury care clinics, ensuring patients receive cohesive, evidence-based treatment across disciplines.

Final Thoughts: Never Miss the Opportunity to Resolve Upstream Biology

If there is one message I want to leave you with, it is this: persistent systemic inflammation is a solvable problem when addressed comprehensively. By restoring immune regulation, supporting mitochondrial function, balancing autonomic tone, and correcting mechanical and lifestyle drivers, we can move biology from chronic defense to repair. That shift reduces risk across cardiometabolic and neurodegenerative pathways and improves daily life—energy, mood, pain, cognition.

I invite you to explore integrative care in a medically supervised, chiropractic-led setting. Together with Dr. Cardenas and our team, we aim to help you complete the inflammatory cycle and reclaim resilient health.

References

• Inflammation, IL-6, TNF-alpha, and Mortality Risk (Balachandran et al., 2022). The Lancet. Demonstrates that elevated IL-6 and TNF-alpha levels independently predict all-cause mortality, comparable to smoking risk. https://doi.org/10.1016/S0140-6736
• Inflammaging and Chronic Disease (Furman et al., 2019). Nature Medicine. Reviews and synthesizes evidence linking chronic low-grade inflammation to cardiometabolic and neurodegenerative conditions. https://www.nature.com/articles/nm
• Immunosenescence and the Inflammatory Phenotype (Franceschi et al., 2018). The Journals of Gerontology: Series A. Explores inflammaging as a hallmark of aging and disease risk. https://academic.oup.com/biomedgerontology
• Neuroinflammation in Alzheimer’s Disease (Heneka et al., 2015). Nature Reviews Neuroscience. Details microglial activation and the neuroinflammatory mechanisms underlying neurodegeneration. https://www.nature.com/articles/nrn
• Systemic Inflammation and Cognitive Decline (Holmes et al., 2009). Journal of Neurology, Neurosurgery & Psychiatry. Links systemic inflammatory markers to cognitive decline in neurodegenerative disease. https://www.ncbi.nlm.nih.gov/pubmed
• Thymosin Alpha-1: Immune Modulation (Gao et al., 2010). Frontiers in Immunology. Discusses the role of Thymosin alpha-1 in modulating immune function and supporting Treg activity. https://www.frontiersin.org/journals/immunology
• Clinical Effects of Thymosin Alpha-1 (Palmieri et al., 2013). Journal of Clinical Immunology. Examines clinical outcomes and mechanisms of T1 therapy. https://link.springer.com/journal
• Personal Injury Doctor Group: Clinical Observations (Jimenez, A.). Personal Injury Doctor Group. Practice narratives and integrative approaches to injury and inflammation. https://personalinjurydoctorgroup.com/
• Professional Profile and Case Insights (Jimenez, A.). LinkedIn. Professional activities, case highlights, and integrative practice philosophy. https://www.linkedin.com/in/dralexjimenez/

SEO tags: systemic inflammation, macrophage polarization, M1 macrophages, M2 macrophages, IL-6, TNF-alpha, inflammaging, microglia, neuroinflammation, BDNF, thymus, Tregs, Thymosin alpha-1, functional medicine, integrative chiropractic, internal medicine oversight, personal injury clinic, El Paso Texas, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, rehabilitation, autonomic regulation, mitochondrial function, chronic disease prevention, evidence-based care